TrumpRx is primarily for people who pay for their prescriptions out-of-pocket. There may be cheaper generic options at direct ...
GoodRx projects Pharma Direct revenue to grow at least 30% year-over-year in 2026. Management anticipates continued acceleration in condition-specific subscriptions launched in late 2025, with weight ...
In the case of brand-name Crestor (rosuvastatin), the average retail price is close to $400 for one month, while a three-month supply at a national pharmacy is $780. For generic rosuvastatin (which ...
The Trump administration’s new website, TrumpRx, is a poor imitation of GoodRx with fewer options, and does not provide real ...
Fourth Quarter and Full Year 2025 Revenue and Adjusted EBITDA Results In-line with Previous GuidancePharma Direct Revenue Beats Previous Outlook with Over 40% Year-Over-Year Growth for 2025SANTA ...
GoodRx (Nasdaq: GDRX), the leading platform for prescription savings in the U.S., today announced the launch of GoodRx ...
Put simply, TrumpRx is designed to “help uninsured Americans find discounted prices for high-cost, brand-name prescriptions, including fertility, obesity and diabetes treatments,” said the LA Times.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results